Sublime
An inspiration engine for ideas

Today, we announced a $200M round led by Addition, @a16z, @lightspeedvp, and Valor, with participation from existing investors @ThriveCapital, Altimeter, Trust Ventures, and @terraincap.
Addition founder Lee Fixel will join our board alongside Antonio Gracias of Valor. https://t.co/TsdPzAwcLo


Royalty Pharma is a fascinating business.
The name pretty much explains the business model -- they purchase royalty streams from academia, biotech, and pharma companies.
It's, unsurprisingly, insane profitable.
63% EBIT margins and 127% operating cash flow... See more
Shulk
@davidnkln
PkqHkjvlRBnN
@pkqhkjvlrbnn
Warp Star
@warpstar-5b60

$NVO was once a market darling, now it gets a garbage treatment.
Yet, revenue is exploding, margins are expanding and it has blockbuster drugs in the pipeline.
Here is why $NVO is a 2x opportunity now: ๐งต https://t.co/nggZELQn80
Dreamforged
@koryrogers
sol niger
baja โข 38 cards
